524322 KABRADG

Kabra Drugs Share Price

 

Stock Result Declared

 

Start SIP in KABRADG

Start SIP

Performance

  • Low
  • ₹33
  • High
  • ₹35
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹36
  • Open Price₹33
  • Previous Close₹33
  • Volume130,162
  • 50 DMA₹28.82
  • 100 DMA₹25.99
  • 200 DMA₹21.35

Investment Returns

  • Over 1 Month + 20.32%
  • Over 3 Month + 55.39%
  • Over 6 Month + 67.16%
  • Over 1 Year + 219.6%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.6
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 80
  • P/B Ratio
  • 3.1
  • Average True Range
  • 1.87
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.86
  • RSI
  • 70.34
  • MFI
  • 80.77

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹33.75
+ 0.46 (1.38%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹30.73
  • 50 Day
  • ₹28.82
  • 100 Day
  • ₹25.99
  • 200 Day
  • ₹21.35

Resistance and Support

33.7 Pivot Speed
  • R3 37.10
  • R2 35.95
  • R1 34.85
  • S1 32.60
  • S2 31.45
  • S3 30.35

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results
2025-10-08 Others Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters.
2025-09-02 Others Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters.

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
91.43%
8.57%

About Kabra Drugs

  • NSE Symbol
  • KABRADG
  • BSE Symbol
  • 524322
  • Managing Director
  • Mr. N Aravind
  • ISIN
  • INE323K01017

Similar Stocks to Kabra Drugs

Kabra Drugs FAQs

Kabra Drugs share price is ₹33 As on 14 February, 2026 | 12:23

The Market Cap of Kabra Drugs is ₹80 Cr As on 14 February, 2026 | 12:23

The P/E ratio of Kabra Drugs is 18.6 As on 14 February, 2026 | 12:23

The PB ratio of Kabra Drugs is 3.1 As on 14 February, 2026 | 12:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23